[{"Assets_0_Q3_USD":3198325000.0,"CommonStockSharesOutstanding_0_Q3_shares":252683346.0,"EarningsPerShareBasic_1_Q3_USD":-0.41,"EarningsPerShareBasic_3_Q3_USD":0.66,"EarningsPerShareDiluted_1_Q3_USD":-0.41,"EarningsPerShareDiluted_3_Q3_USD":0.64,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":617431000.0,"NetIncomeLoss_1_Q3_USD":-102952000.0,"NetIncomeLoss_3_Q3_USD":162800000.0,"StockholdersEquity_0_Q3_USD":1791077000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":250268000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":252095000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":250268000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":247963000.0,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20171030"}]